Treatment of deep vein thrombosis with streptokinase. 1975

F Duckert, and G Müller, and D Nyman, and A Benz, and S Prisender, and G Madar, and M A Da Silva, and L K Widmer, and H E Schmitt

From September 1962 to May 1972 145 patients with acute or subacute deep vein thrombosis confirmed by phlebography were treated with streptokinase. During the same period 42 patients considered unfit for thrombolytic therapy were treated with herapin and oral anticoagulants. The results, assessed by repeat phlebography, in 93 of the patients treated with streptokinase were compared with those in 42 patients treated with heparin. The age, sex, and severity of occlusion were roughly similar in both groups. Streptokinase treatment was successful in 42 per cent, partially successful in 25 per cent, and unsuccessful in 32 per cent of the 93 patients compared with none, 10 per cent, and 88 percent respectively in the 42 patients treated with heparin. Streptokinase was more effective when the thrombus was in proximal rather than calf veins. Thrombi of more than six days old were readily lysed. Plasma fibrinogen levels were below 0-8 g/1 (80 mg/100 ml) in nearly all patients successfully treated. The incidence of pulmonary embolism was no greater with streptokinase than with heparin treatment. Only prolonged follow-up would show whether thrombolytic treatment would be effective in preventing late complications of deep vein thrombosis such as chronic venous insufficiency.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010958 Plasminogen Precursor of plasmin (FIBRINOLYSIN). It is a single-chain beta-globulin of molecular weight 80-90,000 found mostly in association with fibrinogen in plasma; plasminogen activators change it to fibrinolysin. It is used in wound debriding and has been investigated as a thrombolytic agent. Profibrinolysin,Glu-Plasminogen,Glutamic Acid 1-Plasminogen,Glutamyl Plasminogen,1-Plasminogen, Glutamic Acid,Glu Plasminogen,Glutamic Acid 1 Plasminogen,Plasminogen, Glutamyl
D011517 Prothrombin Time Clotting time of PLASMA recalcified in the presence of excess TISSUE THROMBOPLASTIN. Factors measured are FIBRINOGEN; PROTHROMBIN; FACTOR V; FACTOR VII; and FACTOR X. It is used for monitoring anticoagulant therapy with COUMARINS. Quick Test,Russell's Viper Venom Time,Thrombotest,Russell Viper Venom Time,Russells Viper Venom Time,Prothrombin Times,Test, Quick,Time, Prothrombin,Times, Prothrombin
D011655 Pulmonary Embolism Blocking of the PULMONARY ARTERY or one of its branches by an EMBOLUS. Pulmonary Thromboembolism,Thromboembolism, Pulmonary,Embolism, Pulmonary,Embolisms, Pulmonary,Pulmonary Embolisms,Pulmonary Thromboembolisms,Thromboembolisms, Pulmonary
D001778 Blood Coagulation Disorders Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions. Coagulation Disorders, Blood,Disorders, Blood Coagulation,Blood Coagulation Disorder,Coagulation Disorder, Blood,Disorder, Blood Coagulation
D001779 Blood Coagulation Factors Endogenous substances, usually proteins, that are involved in the blood coagulation process. Clotting Factor,Coagulation Factors,Blood Coagulation Factor,Clotting Factors,Coagulation Factor,Coagulation Factor, Blood,Coagulation Factors, Blood,Factor, Coagulation,Factors, Coagulation,Factor, Blood Coagulation,Factor, Clotting,Factors, Blood Coagulation,Factors, Clotting
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen

Related Publications

F Duckert, and G Müller, and D Nyman, and A Benz, and S Prisender, and G Madar, and M A Da Silva, and L K Widmer, and H E Schmitt
March 1969, The British journal of surgery,
F Duckert, and G Müller, and D Nyman, and A Benz, and S Prisender, and G Madar, and M A Da Silva, and L K Widmer, and H E Schmitt
October 1977, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
F Duckert, and G Müller, and D Nyman, and A Benz, and S Prisender, and G Madar, and M A Da Silva, and L K Widmer, and H E Schmitt
January 1988, Haemostasis,
F Duckert, and G Müller, and D Nyman, and A Benz, and S Prisender, and G Madar, and M A Da Silva, and L K Widmer, and H E Schmitt
February 1977, Thrombosis and haemostasis,
F Duckert, and G Müller, and D Nyman, and A Benz, and S Prisender, and G Madar, and M A Da Silva, and L K Widmer, and H E Schmitt
September 1968, British medical journal,
F Duckert, and G Müller, and D Nyman, and A Benz, and S Prisender, and G Madar, and M A Da Silva, and L K Widmer, and H E Schmitt
July 1977, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
F Duckert, and G Müller, and D Nyman, and A Benz, and S Prisender, and G Madar, and M A Da Silva, and L K Widmer, and H E Schmitt
October 1975, Lancet (London, England),
F Duckert, and G Müller, and D Nyman, and A Benz, and S Prisender, and G Madar, and M A Da Silva, and L K Widmer, and H E Schmitt
June 1973, The British journal of surgery,
F Duckert, and G Müller, and D Nyman, and A Benz, and S Prisender, and G Madar, and M A Da Silva, and L K Widmer, and H E Schmitt
July 1972, Journal of clinical pathology,
F Duckert, and G Müller, and D Nyman, and A Benz, and S Prisender, and G Madar, and M A Da Silva, and L K Widmer, and H E Schmitt
February 1973, Nursing times,
Copied contents to your clipboard!